Need a fix of some stem cell good news? I do. It has been a bumpy 2016 so far for the stem cell field and many challenges have popped up. So today at lunch and needing at least a short break from grant writing, I went looking for stem cell good news including interesting studies, promising […]
List of 11 stem cell good news or interesting stories Read More »
By Elliot Hosman Summary. A campaign calling for a moratorium on using CRISPR in human embryos was launched by a prominent French organization fighting for narrow understandings of life and family. A recent campaign calling for a ban on “transgenic” human embryos was launched by one of France’s most prominent organizations fighting for “science”-backed “one-man-one-woman”
Hateful politics infiltrate human genome editing debate in France Read More »
Now that the ISSCR annual meeting is over, some overall stem cell trends are evident from the meeting in terms of the direction of the stem cell field. This was one of my favorite ISSCR meetings. Translation expectation and upbeat tone. The overall vibe at the meeting was a sense of excitement and optimism about the
5 big picture stem cell trends at ISSCR 2016 Read More »
I wrote yesterday about two cases of science media hype on CRISPR and on stem cells for strokes. The latter case on stem cell hype stirred the most discussion and even some harsh words in the comments. As this stem cell stroke story on an encouraging but very small, preliminary study has unfolded across the
Stem cells for stroke hype analysis: 9 very different headlines Read More »
Over on Twitter Magdalena Plotczyk (@MPlotczyk) posted a striking photo of an anti-GMO poster from Lausanne, Switzerland. The top part of the poster translates as, “‘After GMO corn, GMO children?’” As readers of this blog know, I do have concerns about the eventual production of genetically modified people using rapidly evolving genetic modification/gene editing technology such as CRISPR.
Anti-GMO poster in Switzerland invokes human GMOs Read More »
A committee of the International Society for Stem Cell Research (ISSCR) did one heck of a document dump yesterday on stem cell policy, releasing a whole bunch of policy recommendations on stem cells and more. The torrent from ISSCR included a 37-page policy statement itself as well as several papers in top journals including the
ISSCR Releases Flood of Stem Cell Policy Docs Read More »
Editor’s note. Caroline Simons attended both the April 28th (see her report on that here) and 29th Paris meetings on human gene editing/genetic modification. Today, we have her in depth report on the April 29th meeting. I have posted her piece in full with only minor edits. If you are in a rush you can
In Depth Report from April 29th Paris Human Gene Editing Meeting Read More »
Editors note: This is a guest post from Caroline Simons who is attending the two Paris meetings on human gene editing. For more background on those meetings see here. By Caroline Simons There were just over a hundred participants at the workshop organized by the Federation of European Academies of Medicine, the UK Academy of
Paris human gene editing workshop summary Read More »
This week there will be two meetings in Paris as part of the ongoing international dialogue on human genetic modification/human gene editing, CRISPR, and figuring out a wise path forward. A one-day workshop will be held on April 28th “jointly organised by the Federation of European Academies of Medicine (FEAM), the UK Academy of Medical
Scoop on this week’s Paris human gene editing meetings Read More »
A new study on treating pain with a unique stem cell connection caught my attention. The paper was from a team at Pfizer led by Edward B. Stevens. Talk about bench to bedside, these researchers went all the way from patients to patient somatic cells to reprogrammed IPSC to neurons to model pain in a dish
Pain in a dish? Drug testing bench to bedside with IPS cells Read More »